# João Sabino

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/joao-sabino/

## Facts

| Field | Value |
| --- | --- |
| Citations | 9,603 |
| Field | Inflammatory Bowel Disease |
| h-index | 34 |
| i10-index | 67 |
| Last Known Institution | Universitair Ziekenhuis Leuven |
| OpenAlex ID | https://openalex.org/A5077041880 |
| ORCID iD | 0000-0002-8892-7075 |
| Works | 321 |

## Researcher papers

- [A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis](https://scholariq.org/papers/a-decrease-of-the-butyrate-producing-species-i-roseburia-hominis-i-and-i/)
- [ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-medical-treatment/)
- [Quantitative microbiome profiling links gut community variation to microbial load](https://scholariq.org/papers/quantitative-microbiome-profiling-links-gut-community-variation-to-microbial/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-surgical-treatment/)
- [Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD](https://scholariq.org/papers/primary-sclerosing-cholangitis-is-characterised-by-intestinal-dysbiosis/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-medical-treatment-2/)
- [Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses](https://scholariq.org/papers/quantitative-microbiome-profiling-disentangles-inflammation-and-bile-duct/)
- [Temporal variability in quantitative human gut microbiome profiles and implications for clinical research](https://scholariq.org/papers/temporal-variability-in-quantitative-human-gut-microbiome-profiles-and/)
- [ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment](https://scholariq.org/papers/ecco-guidelines-on-therapeutics-in-crohn-s-disease-surgical-treatment-2/)
- [Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links](https://scholariq.org/papers/inflammatory-bowel-disease-and-parkinson-s-disease-common-pathophysiological/)
- [No Increased Risk of Venous Thromboembolism or Infectious Complications after Janus Kinase Inhibitor Exposure in Patients with Ulcerative Colitis Undergoing Surgery](https://scholariq.org/papers/no-increased-risk-of-venous-thromboembolism-or-infectious-complications-after/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)

## Researcher university

- [Universitair Ziekenhuis Leuven](https://scholariq.org/institutions/universitair-ziekenhuis-leuven/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.